Chemicals from plastic packaging in processed foods may interfere with your hormones, making your body store more fat in the liver and increasing diabetes risk.
Scientific Claim
Exposure to endocrine-disrupting chemicals (EDCs) such as phthalates and bisphenol A (BPA), which leach from packaging into ultra-processed foods, is associated with insulin resistance, adipose tissue dysfunction, and increased risk of MASLD.
Original Statement
“Dietary patterns characterized by high consumption of UPFs have been associated with increased exposure to EDCs... Phthalates... have recently been associated with the development of MASLD in individuals with IR, prediabetes, or T2D. BPA... has been linked to disruptions in pancreatic alpha and beta cell function, contributing to the development of IR and T2D.”
Evidence Quality Assessment
Claim Status
overstated
Study Design Support
Design supports claim
Appropriate Language Strength
association
Can only show association/correlation
Assessment Explanation
The association between EDCs and MASLD is based on indirect evidence (dietary patterns → presumed exposure → disease). No study in the review directly measures EDC levels and links them to MASLD outcomes in the same cohort.
More Accurate Statement
“Higher consumption of ultra-processed foods is associated with increased exposure to endocrine-disrupting chemicals such as phthalates and bisphenol A, which are independently linked to insulin resistance and metabolic dysfunction-associated steatotic liver disease in observational studies.”
Gold Standard Evidence Needed
According to GRADE and EBM methodology, here is what ideal scientific evidence would look like to definitively prove or disprove this specific claim, ordered from strongest to weakest evidence.
Prospective Cohort StudyLevel 2bWhether urinary levels of phthalates and BPA predict incident MASLD after adjusting for UPF intake and metabolic confounders.
Whether urinary levels of phthalates and BPA predict incident MASLD after adjusting for UPF intake and metabolic confounders.
What This Would Prove
Whether urinary levels of phthalates and BPA predict incident MASLD after adjusting for UPF intake and metabolic confounders.
Ideal Study Design
A 7-year prospective cohort of 3,000 adults with annual urinary measurements of phthalate metabolites and BPA, UPF intake via FFQ, and liver fat assessed by MRI-PDFF at baseline and endpoint, adjusting for BMI, T2D, and diet quality.
Limitation: EDC levels fluctuate daily; single measurements may not reflect chronic exposure.
Case-Control StudyLevel 3Whether individuals with biopsy-proven MASH have higher levels of EDCs than those with simple steatosis or no liver disease.
Whether individuals with biopsy-proven MASH have higher levels of EDCs than those with simple steatosis or no liver disease.
What This Would Prove
Whether individuals with biopsy-proven MASH have higher levels of EDCs than those with simple steatosis or no liver disease.
Ideal Study Design
A matched case-control study of 200 individuals with biopsy-proven MASLD (100 simple steatosis, 100 MASH) and 100 controls, measuring serum and urinary levels of 10 key EDCs (phthalates, BPA, PCBs) and adjusting for UPF intake, BMI, and alcohol.
Limitation: Cannot establish temporal sequence; biopsy not routinely performed.
Animal Model StudyLevel 4Whether low-dose chronic exposure to BPA or phthalates induces hepatic steatosis and insulin resistance independent of caloric intake.
Whether low-dose chronic exposure to BPA or phthalates induces hepatic steatosis and insulin resistance independent of caloric intake.
What This Would Prove
Whether low-dose chronic exposure to BPA or phthalates induces hepatic steatosis and insulin resistance independent of caloric intake.
Ideal Study Design
A 24-week study in C57BL/6 mice fed a low-fat diet with chronic low-dose BPA (50 µg/kg/day) or DEHP (500 µg/kg/day) vs. vehicle control, measuring insulin sensitivity (HOMA-IR), liver fat (histology), and adipose tissue inflammation.
Limitation: Dose translation to humans is uncertain; mice are not perfect models for human EDC metabolism.
Evidence from Studies
Supporting (1)
This study says eating lots of highly processed foods (like chips, sodas, and frozen meals) is linked to liver fat buildup and metabolic problems—exactly what the claim says happens because of chemicals from the packaging. Even though it doesn’t measure the chemicals directly, it still supports the idea.